If your company is not based in Ghana, you cannot register a product directly with the Food and Drugs Authority on your own. This surprises a number of international manufacturers who assume the process works the same way it does in their home market. It does not — and understanding why matters before you commit time or budget to a Ghana submission.
What Ghana FDA actually requires
Ghana FDA's registration guidelines for allopathic drugs state it plainly: every applicant who is not resident in Ghana must appoint one local representative — a company incorporated in Ghana, authorised by the FDA to import medicinal products, and holding a valid wholesale dealer's licence. This requirement sits within Part 7 of the Public Health Act, 2012 (Act 851), the section of the Act that governs product registration in Ghana.
For biological products specifically, the equivalent guidelines use the term local agent, defined as a registered pharmaceutical wholesale company or an FDA-accredited manufacturer's representative who is also a pharmacist registered in Ghana. The terminology differs slightly by product category; the underlying obligation does not.
What the role actually involves
A local representative is not a formality on an application form. Once appointed, they:
- Submit and hold the registration on the foreign company's behalf
- Receive and respond to FDA queries during evaluation
- Carry pharmacovigilance and safety-reporting responsibility for the product once it's on the market
- Represent the product to the Authority for as long as it remains registered — not just through approval
That last point is where companies most often underestimate the decision. Market access stays tied to the diligence of whoever holds this role long after the certificate is issued, through renewals, variations and inspections.
Choosing a representative
The FDA requirement is narrow — incorporated in Ghana, authorised to import, wholesale-licensed — but the practical requirement is broader. A representative who treats the role as paperwork rather than an ongoing accountability is a liability you inherit later, usually at the worst possible moment: a query response deadline, a safety signal, an audit. Vet a prospective representative the way you would vet any regulatory partner carrying legal accountability for your product.
Where this fits in your market entry plan
Appointing a local representative is typically one of the first steps in a Ghana submission, not an afterthought once the dossier is ready. Sequencing it early avoids a scramble later, and a representative involved from the start can flag Ghana-specific requirements — labelling, stability data, documentation — before they become costly surprises mid-process.
Entering the Ghanaian market as a foreign manufacturer?
We act as the in-country regulatory partner international companies need to register and stay compliant.
Start your engagement →